Table 2.

Clinical characteristics of patients with brain metastasis of uterine cervical cancer

No.	Age at BM, yr	Interval to BM, mon	OS after BM, mon	Patient status	KPS score at BM	Histology	Initial FIGO stage	CTx regimen before BM	Controlled primary state	Extracranial meta	No. of BM	Local Tx after BM	CTx after BM	RPA	GPA
1	51	70	18	Dead	50	SQ	IIB	2	Yes	Yes	5	No	Yes	3	0.5
2	45	93	27	Dead	60	SQ	IB2	1	No	Yes	1	RT	Yes	3	2
3	75	63	4	Dead	50	SQ	IIB	0	Yes	Yes	1	No	Yes	3	1
4	34	14	1	Dead	50	SC	IB2	3	No	Yes	> 10	RT	No	3	1
5	53	38	2	Dead	60	SQ	IIB	5	Yes	Yes	4	RT	No	3	0.5
6	58	45	11	Dead	80	SQ	IIB	1	Yes	Yes	1	OP + RT	Yes	2	2
7	69	166	10	Dead	20	SQ	IIB	1	Yes	Yes	3	RT	No	3	0.5
8	45	17	9	Dead	80	SC	IIA2	2	Yes	No	1	OP + RT	Yes	1	3.5
9	53	9	23	Dead	80	SC	IVB	2	Yes	Yes	1	OP + RT	Yes	2	2
10	55	16	0	Dead	50	AD	IB1	3	No	Yes	> 10	No	No	3	0.5
11	31	19	1	Dead	20	AS	IIB	1	Yes	Yes	1	No	No	3	2
12	50	10	73	Alive	70	SC	IIB	1	Yes	No	1	OP + RT	Yes	1	3
13	71	15	15	Dead	80	AD	IB1	1	Yes	Yes	1	OP + RT	Yes	2	1.5
14	58	25	6	FU loss	60	CS	IVB	2	Yes	Yes	1	OP + RT	Yes	3	1.5
15	55	27	6	Dead	70	AD	IIB	3	Yes	Yes	3	RT	Yes	2	1.5
16	40	19	8	Alive	80	SQ	IVB	3	No	Yes	> 10	RT	Yes	2	1.5
17	53	23	4	Alive	80	SQ	IIB	2	Yes	No	2	RT	Yes	1	2.5
18	58	6	2	Dead	80	SQ	IVB	1	Yes	Yes	1	RT	No	2	2
19	74	9	5	FU loss	70	SQ	IIB	1	Yes	Yes	1	RT	Yes	2	1.5

BM, brain metastasis; OS, overall survival; KPS, Karnofsky performance status; FIGO, International Federation of Gynecology and Obstetrics; CTx, chemotherapy; Tx, therapy; PRA, recursive partitioning analysis; GPA, graded prognostic assessment; SQ, squamous cell carcinoma; RT, radiotherapy; SC, small cell carcinoma; OP, surgery; AD, adenocarcinoma; AS, adenosquamous cell carcinoma; FU, follow-up; CS, carcinosarcoma.